Author: | Biopharma Advantage Consulting L.L.C., FDA | ISBN: | 1230000227697 |
Publisher: | Biopharma Advantage Consulting L.L.C. | Publication: | March 23, 2014 |
Imprint: | Language: | English |
Author: | Biopharma Advantage Consulting L.L.C., FDA |
ISBN: | 1230000227697 |
Publisher: | Biopharma Advantage Consulting L.L.C. |
Publication: | March 23, 2014 |
Imprint: | |
Language: | English |
Regulations on: Drug Labeling, Drug Advertising, Drug Marketing, Drug Imprinting, Drug Names, Promotional Materials
PART 99 DISSEMINATION OF INFORMATION ON UNAPPROVED/NEW USES FOR MARKETED DRUGS, BIOLOGICS, AND DEVICES
PART 200 GENERAL
PART 201 LABELING
PART 202 PRESCRIPTION DRUG ADVERTISING
PART 203 PRESCRIPTION DRUG MARKETING
PART 206 IMPRINTING OF SOLID ORAL DOSAGE FORM DRUG PRODUCTS FOR HUMAN USE
PART 208 MEDICATION GUIDES FOR PRESCRIPTION DRUG PRODUCTS
PART 299 DRUGS; OFFICIAL NAMES AND ESTABLISHED NAMES
SEC. 312.7 PROM0TION OF INVESTIGATIONAL DRUGS
SEC. 314.81 OTHER POSTMARKETING REPORTS
SEC. 314.550 PROMOTIONAL MATERIALS
SEC. 314.560 TERMINATION OF REQUIREMENTS
Regulations on: Drug Labeling, Drug Advertising, Drug Marketing, Drug Imprinting, Drug Names, Promotional Materials
PART 99 DISSEMINATION OF INFORMATION ON UNAPPROVED/NEW USES FOR MARKETED DRUGS, BIOLOGICS, AND DEVICES
PART 200 GENERAL
PART 201 LABELING
PART 202 PRESCRIPTION DRUG ADVERTISING
PART 203 PRESCRIPTION DRUG MARKETING
PART 206 IMPRINTING OF SOLID ORAL DOSAGE FORM DRUG PRODUCTS FOR HUMAN USE
PART 208 MEDICATION GUIDES FOR PRESCRIPTION DRUG PRODUCTS
PART 299 DRUGS; OFFICIAL NAMES AND ESTABLISHED NAMES
SEC. 312.7 PROM0TION OF INVESTIGATIONAL DRUGS
SEC. 314.81 OTHER POSTMARKETING REPORTS
SEC. 314.550 PROMOTIONAL MATERIALS
SEC. 314.560 TERMINATION OF REQUIREMENTS